Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon.

Literature DB >> 29948291

Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon.

Tobias Rheude¹, Costanza Pellegrini¹, Jonathan Michel¹, Christian Thilo², Michael Joner¹, Albert Markus Kasel³.

Abstract

Mesh：

Year: 2018 PMID： 29948291 DOI： 10.1007/s00392-018-1301-8

Source DB: PubMed Journal: Clin Res Cardiol ISSN： 1861-0684 Impact factor: 5.460

Keyword Cloud
References

× No keyword cloud information.

14 in total

1. Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: A Feasibility Study.

Authors: Anupama Shivaraju; Susheel Kodali; Christian Thilo; Ilka Ott; Heribert Schunkert; Wolfgang von Scheidt; Martin B Leon; Adnan Kastrati; Albert M Kasel
Journal: JACC Cardiovasc Interv Date: 2015-12-28 Impact factor: 11.195

2. Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation.

Authors: Andreas Schaefer; Niklas Neumann; Matthias Linder; Niklas Schofer; Yvonne Schneeberger; Florian Deuschl; Gerhard Schoen; Stefan Blankenberg; Hermann Reichenspurner; Lenard Conradi; Ulrich Schäfer
Journal: Clin Res Cardiol Date: 2018-04-28 Impact factor: 5.460

3. Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification.

Authors: Won-Keun Kim; Johannes Blumenstein; Christoph Liebetrau; Andreas Rolf; Luise Gaede; Arnaud Van Linden; Mani Arsalan; Mirko Doss; Jan G P Tijssen; Christian W Hamm; Thomas Walther; Helge Möllmann
Journal: Clin Res Cardiol Date: 2017-08-09 Impact factor: 5.460

4. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.

Authors: Birgid Gonska; Julia Seeger; Mirjam Keßler; Alexander von Keil; Wolfgang Rottbauer; Jochen Wöhrle
Journal: Clin Res Cardiol Date: 2017-03-10 Impact factor: 5.460

5. Cardiopulmonary exercise testing is predictive of return to work in cardiac patients after multicomponent rehabilitation.

Authors: Annett Salzwedel; Rona Reibis; Karl Wegscheider; Sarah Eichler; Hermann Buhlert; Stefan Kaminski; Heinz Völler
Journal: Clin Res Cardiol Date: 2015-09-16 Impact factor: 5.460

6. Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions.

Authors: Andreas Schaefer; Matthias Linder; Hendrik Treede; Florian Deuschl; Niklas Schofer; Moritz Seiffert; Yvonne Schneeberger; Stefan Blankenberg; Hermann Reichenspurner; Ulrich Schaefer; Lenard Conradi
Journal: Clin Res Cardiol Date: 2015-12-17 Impact factor: 5.460

Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon.

1. Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: A Feasibility Study.

2. Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation.

3. Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification.

4. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.

5. Cardiopulmonary exercise testing is predictive of return to work in cardiac patients after multicomponent rehabilitation.

6. Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions.

7. Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.

Review 8. Review of reported causes of device embolization following trans-catheter aortic valve implantation.

9. A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation.

10. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation.